These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24378145)

  • 1. [Proportion of breast cancer in women aged 50 to 69 years from Girona, Spain, according to detection method].
    Puig-Vives M; Osca-Gelis G; Camprubí-Font C; Vilardell ML; Izquierdo A; Marcos-Gragera R
    Med Clin (Barc); 2014 Oct; 143(7):300-2. PubMed ID: 24378145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983-2007.
    Puig-Vives M; Pollan M; Rue M; Osca-Gelis G; Saez M; Izquierdo A; Marcos-Gragera R
    Breast; 2012 Oct; 21(5):646-51. PubMed ID: 22340960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
    Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
    Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
    Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
    Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Classification and characteristics of interval cancers in the Principality of Asturias's Breast Cancer Screening Program].
    Prieto García MA; Delgado Sevillano R; Baldó Sierra C; González Díaz E; López Secades A; Llavona Amor JA; Vidal Marín B
    Radiologia; 2013 Sep; 55(5):408-15. PubMed ID: 22520555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathological characteristics in screening versus clinically-detected breast cancer].
    Paziault M; Terrade FX; Fermeaux V; Pascal B; Darreye G; Dussartre C; Gilquin M; Labrousse F; Tubiana-Mathieu N
    Bull Cancer; 2006 Jul; 93(7):731-6. PubMed ID: 16873082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Breast cancer incidence related with a population-based screening program].
    Natal C; Caicoya M; Prieto M; Tardón A
    Med Clin (Barc); 2015 Feb; 144(4):156-60. PubMed ID: 25194975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry.
    Iwamoto T; Kumamaru H; Miyata H; Tomotaki A; Niikura N; Kawai M; Anan K; Hayashi N; Masuda S; Tsugawa K; Aogi K; Ishida T; Masuoka H; Iijima K; Matsuoka J; Doihara H; Kinoshita T; Nakamura S; Tokuda Y
    Breast Cancer Res Treat; 2016 Apr; 156(3):485-494. PubMed ID: 27048417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study.
    de Glas NA; de Craen AJ; Bastiaannet E; Op 't Land EG; Kiderlen M; van de Water W; Siesling S; Portielje JE; Schuttevaer HM; de Bock GT; van de Velde CJ; Liefers GJ
    BMJ; 2014 Sep; 349():g5410. PubMed ID: 25224469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative risk of cancer detection in breast cancer screening by protocol strategy.
    Blanch J; Sala M; Román M; Ederra M; Salas D; Zubizarreta R; Sanchez M; Rué M; Castells X;
    Breast Cancer Res Treat; 2013 Apr; 138(3):869-77. PubMed ID: 23471648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer screening at the Breast Examination Center of Harlem.
    Manning AT; Eaton A; Azu M; Sampson M; Patil S; Godfrey D; Beesen AA; Liberman L; Gemignani ML
    Ann Surg Oncol; 2015; 22(6):2026-33. PubMed ID: 25448800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program.
    Møller P; Stormorken A; Jonsrud C; Holmen MM; Hagen AI; Clark N; Vabø A; Sun P; Narod SA; Mæhle L
    Breast Cancer Res Treat; 2013 May; 139(1):155-61. PubMed ID: 23615785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
    Chiarelli AM; Prummel MV; Muradali D; Majpruz V; Horgan M; Carroll JC; Eisen A; Meschino WS; Shumak RS; Warner E; Rabeneck L
    J Clin Oncol; 2014 Jul; 32(21):2224-30. PubMed ID: 24934793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interval cancers in the Dutch breast cancer screening programme.
    Fracheboud J; de Koning HJ; Beemsterboer PM; Boer R; Verbeek AL; Hendriks JH; van Ineveld BM; Broeders MJ; de Bruyn AE; van der Maas PJ
    Br J Cancer; 1999 Nov; 81(5):912-7. PubMed ID: 10555768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening caused rising incidence rates of ductal carcinoma in situ of the breast.
    van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
    Breast Cancer Res Treat; 2009 May; 115(1):181-3. PubMed ID: 18516674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of organised mammography screening on stage-specific incidence in Norway: population study.
    Lousdal ML; Kristiansen IS; Møller B; Støvring H
    Br J Cancer; 2016 Mar; 114(5):590-6. PubMed ID: 26835975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of breast cancer screening in Denmark.
    Lynge E; Bak M; von Euler-Chelpin M; Kroman N; Lernevall A; Mogensen NB; Schwartz W; Wronecki AJ; Vejborg I
    BMC Cancer; 2017 Dec; 17(1):897. PubMed ID: 29282034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.